Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003.

Cheng, Jonathan D

Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research May 2003 - 1590-5 p. digital

Publication Type: Journal Article; Comment

1078-0432


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antigens, Neoplasm--metabolism
Biomarkers, Tumor--metabolism
Clinical Trials, Phase I as Topic
Colonic Neoplasms--drug therapy
Endopeptidases
Gelatinases
Humans
Lung Neoplasms--drug therapy
Membrane Proteins
Serine Endopeptidases--metabolism